Skip to main content
logo
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.930
-0.010 (-0.34%)
At close: Jun 16, 2026, 4:00 PM EDT
2.924
-0.006 (-0.20%)
After-hours: Jun 16, 2026, 8:00 PM EDT

Perspective Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Revenue
0.620.881.451.43--
Revenue Growth (YoY)
-57.99%-39.20%1.40%---
Gross Profit
0.620.881.451.43--
Selling, General & Admin
29.3830.2326.6121.067.495.57
Research & Development
91.2684.2241.6421.310.880.85
Other Operating Expenses
--24.09-0.31-
Total Operating Expenses
120.63114.4592.3442.388.676.42
Operating Income
-120.01-113.56-90.89-40.94-8.67-6.42
Interest Income
7.938.1110.520.930.620.12
Other Non-Operating Income (Expense)
-0.351.54-1.01-9.15-2.71-0.97
Total Non-Operating Income (Expense)
7.579.659.51-8.22-2.09-0.85
Pretax Income
-112.44-103.91-81.38-49.16-10.76-7.27
Provision for Income Taxes
--0.79-2.1-2.65--
Net Income
-111.13-103.12-79.28-46.51-10.76-7.27
Earnings From Discontinued Operations
0.51-----
Net Income to Common
-111.13-103.12-79.28-46.51-10.76-7.27
Shares Outstanding (Basic)
827464271414
Shares Outstanding (Diluted)
827464271414
Shares Change (YoY)
16.41%14.57%140.72%88.39%0.06%316.28%
EPS (Basic)
-1.40-1.40-1.23-1.74-0.80-0.50
EPS (Diluted)
-1.40-1.40-1.23-1.74-0.80-0.50
Free Cash Flow
-107.32-95.23-72.71-37.990-7.98
Free Cash Flow Per Share
-1.31-1.29-1.13-1.42--0.56
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-19419.60%-12846.60%-6250.76%-2855.02%--
Profit Margin
-17982.70%-11665.30%-5452.48%-3243.24%--
FCF Margin
-17365.90%-10773.00%-5000.55%-2648.88%--
EBITDA
-116.37-110.31-88.58-39.96-8.67-6.13
EBITDA Margin
-18829.80%-12478.80%-6092.16%-2786.26%--
EBIT
-120.01-113.56-90.89-40.94-8.67-6.42
EBIT Margin
-19419.60%-12846.60%-6250.76%-2855.02%--
Effective Tax Rate
-0.76%2.58%5.39%0.00%0.00%
SEC Filings: 10-K · 10-Q